Literature DB >> 1426855

Significance of serum sialic acid in patients with Crohn's disease.

R Baba1, K Yashiro, K Nagasako, H Obata.   

Abstract

Serum sialic acid was measured to evaluate the activity of Crohn's disease. The sialic acid levels of patients with Crohn's disease in remission (CRP 0.0 mg/dl) were significantly higher than those of healthy subjects and postoperative patients with Crohn's disease. In patients in remission, serum sialic acid was significantly correlated with hemoglobin, hematocrit, platelet, and rapid turnover protein. Correlations with platelet, retinol-binding protein, and prealbumin were especially strong. From these findings, it was concluded that serum sialic acid level provides a useful index of the activity of Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1426855     DOI: 10.1007/bf02774974

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  6 in total

1.  Enzymatic assay of serum sialic acid.

Authors:  K Sugahara; K Sugimoto; O Nomura; T Usui
Journal:  Clin Chim Acta       Date:  1980-12-22       Impact factor: 3.786

2.  [B. Enzymatic analysis of sialic acids and clinical application. 1. Comparison of the blood serum-sialic acid level and erythrocyte sedimentation rate].

Authors:  T Takada
Journal:  Rinsho Byori       Date:  1983-03

3.  [Comparison among the blood sialic acid level, CRP, protein fractions and mucoprotein content].

Authors:  J Igari; N Kosakai; M Ozawa; S Kawabata
Journal:  Rinsho Byori       Date:  1983-03

4.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

5.  Is tube feeding with elemental diets a primary therapy of Crohn's disease?

Authors:  H Lochs; M Egger-Schödl; R Schuh; S Meryn; G Westphal; R Pötzi
Journal:  Klin Wochenschr       Date:  1984-09-03

6.  Continuous elemental enteral alimentation in the treatment of children and adolescents with Crohn's disease.

Authors:  C L Morin; M Roulet; C C Roy; A Weber; N Lapointe
Journal:  JPEN J Parenter Enteral Nutr       Date:  1982 May-Jun       Impact factor: 4.016

  6 in total
  3 in total

1.  Elevated serum sialic acid in pregnancy.

Authors:  M Crook; S Constable; P Lumb; J Rymer
Journal:  J Clin Pathol       Date:  1997-06       Impact factor: 3.411

2.  Mammalian Neuraminidases in Immune-Mediated Diseases: Mucins and Beyond.

Authors:  Erik P Lillehoj; Irina G Luzina; Sergei P Atamas
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

3.  Altered Bioavailability and Pharmacokinetics in Crohn's Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs.

Authors:  Sarah Alrubia; Jialin Mao; Yuan Chen; Jill Barber; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2022-09-03       Impact factor: 5.577

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.